100 related articles for article (PubMed ID: 35598328)
21. Whole exome sequencing reveals intertumor heterogeneity and distinct genetic origins of sporadic synchronous colorectal cancer.
Di J; Yang H; Jiang B; Wang Z; Ji J; Su X
Int J Cancer; 2018 Mar; 142(5):927-939. PubMed ID: 29105743
[TBL] [Abstract][Full Text] [Related]
22. Genetics of synchronous uterine and ovarian endometrioid carcinoma: combined analyses of loss of heterozygosity, PTEN mutation, and microsatellite instability.
Fujii H; Matsumoto T; Yoshida M; Furugen Y; Takagaki T; Iwabuchi K; Nakata Y; Takagi Y; Moriya T; Ohtsuji N; Ohtsuji M; Hirose S; Shirai T
Hum Pathol; 2002 Apr; 33(4):421-8. PubMed ID: 12055677
[TBL] [Abstract][Full Text] [Related]
23. Single-cell exome sequencing reveals multiple subclones in metastatic colorectal carcinoma.
Tang J; Tu K; Lu K; Zhang J; Luo K; Jin H; Wang L; Yang L; Xiao W; Zhang Q; Liu X; Ge XY; Li G; Zhou Z; Xie D
Genome Med; 2021 Sep; 13(1):148. PubMed ID: 34507604
[TBL] [Abstract][Full Text] [Related]
24. Genetic and clonal dissection of osteosarcoma progression and lung metastasis.
Xu H; Zhu X; Bao H; Wh Shek T; Huang Z; Wang Y; Wu X; Wu Y; Chang Z; Wu S; Tang Q; Zhang H; Han A; Mc Cheung K; Zou C; Yau R; Ho WY; Huang G; Batalha S; Lu J; Song G; Kang Y; Shao YW; Lam YL; Shen J; Wang J
Int J Cancer; 2018 Sep; 143(5):1134-1142. PubMed ID: 29569716
[TBL] [Abstract][Full Text] [Related]
25. Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases.
Ng CKY; Bidard FC; Piscuoglio S; Geyer FC; Lim RS; de Bruijn I; Shen R; Pareja F; Berman SH; Wang L; Pierga JY; Vincent-Salomon A; Viale A; Norton L; Sigal B; Weigelt B; Cottu P; Reis-Filho JS
Clin Cancer Res; 2017 Aug; 23(15):4402-4415. PubMed ID: 28351929
[No Abstract] [Full Text] [Related]
26. Single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer tumors.
Wang R; Li J; Zhou X; Mao Y; Wang W; Gao S; Wang W; Gao Y; Chen K; Yu S; Wu X; Wen L; Ge H; Fu W; Tang F
Genome Med; 2022 Aug; 14(1):93. PubMed ID: 35974387
[TBL] [Abstract][Full Text] [Related]
27. Discrepancy Between Clinical Diagnosis and Whole-exome Sequencing-based Clonality Analysis of Synchronous Multiple Oral Cancers.
Nishii N; Hirotsu Y; Koida N; Takahashi Y; Takagawa Y; Amemiya K; Oyama T; Mochizuki H; Furusawa-Nishii E; Harada H; Omata M
Anticancer Res; 2021 Feb; 41(2):1035-1040. PubMed ID: 33517312
[TBL] [Abstract][Full Text] [Related]
28. The clonal heterogeneity of colon cancer with liver metastases.
Chen G; Zhu W; Liu Y; Zhang L; Xie L; Song X; Song X
J Gastroenterol; 2023 Jul; 58(7):642-655. PubMed ID: 37042990
[TBL] [Abstract][Full Text] [Related]
29. Genetic Alterations in Preinvasive Lung Synchronous Lesions.
Ahn S; Lim J; Park SY; Kim H; Kwon HJ; Han YB; Lee CT; Cho S; Chung JH
Cancer Res Treat; 2020 Oct; 52(4):1120-1134. PubMed ID: 32599981
[TBL] [Abstract][Full Text] [Related]
30. Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma.
Pectasides E; Stachler MD; Derks S; Liu Y; Maron S; Islam M; Alpert L; Kwak H; Kindler H; Polite B; Sharma MR; Allen K; O'Day E; Lomnicki S; Maranto M; Kanteti R; Fitzpatrick C; Weber C; Setia N; Xiao SY; Hart J; Nagy RJ; Kim KM; Choi MG; Min BH; Nason KS; O'Keefe L; Watanabe M; Baba H; Lanman R; Agoston AT; Oh DJ; Dunford A; Thorner AR; Ducar MD; Wollison BM; Coleman HA; Ji Y; Posner MC; Roggin K; Turaga K; Chang P; Hogarth K; Siddiqui U; Gelrud A; Ha G; Freeman SS; Rhoades J; Reed S; Gydush G; Rotem D; Davison J; Imamura Y; Adalsteinsson V; Lee J; Bass AJ; Catenacci DV
Cancer Discov; 2018 Jan; 8(1):37-48. PubMed ID: 28978556
[TBL] [Abstract][Full Text] [Related]
31. Clonal Evolution and Timing of Metastatic Colorectal Cancer.
Siraj S; Masoodi T; Siraj AK; Azam S; Qadri Z; Ahmed SO; AlBalawy WN; Al-Obaisi KA; Parvathareddy SK; AlManea HM; AlHussaini HF; Abduljabbar A; Alhomoud S; Al-Dayel FH; Alkuraya FS; Al-Kuraya KS
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33053768
[TBL] [Abstract][Full Text] [Related]
32. Mutational profiles of breast cancer metastases from a rapid autopsy series reveal multiple evolutionary trajectories.
Avigdor BE; Cimino-Mathews A; DeMarzo AM; Hicks JL; Shin J; Sukumar S; Fetting J; Argani P; Park BH; Wheelan SJ
JCI Insight; 2017 Dec; 2(24):. PubMed ID: 29263308
[TBL] [Abstract][Full Text] [Related]
33. Spatio-Temporal Genomic Heterogeneity, Phylogeny, and Metastatic Evolution in Salivary Adenoid Cystic Carcinoma.
Liu B; Mitani Y; Rao X; Zafereo M; Zhang J; Zhang J; Futreal PA; Lozano G; El-Naggar AK
J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 29117356
[TBL] [Abstract][Full Text] [Related]
34. Subclonal Genomic Architectures of Primary and Metastatic Colorectal Cancer Based on Intratumoral Genetic Heterogeneity.
Kim TM; Jung SH; An CH; Lee SH; Baek IP; Kim MS; Park SW; Rhee JK; Lee SH; Chung YJ
Clin Cancer Res; 2015 Oct; 21(19):4461-72. PubMed ID: 25979483
[TBL] [Abstract][Full Text] [Related]
35. Clonal origin of lymph node metastases in bladder carcinoma.
Jones TD; Carr MD; Eble JN; Wang M; Lopez-Beltran A; Cheng L
Cancer; 2005 Nov; 104(9):1901-10. PubMed ID: 16196038
[TBL] [Abstract][Full Text] [Related]
36. Utility of whole exome sequencing analysis in differentiating intrapulmonary metastatic multiple ground-glass nodules (GGNs) from multiple primary GGNs.
Zhou D; Liu QX; Li MY; Hou B; Yang GX; Lu X; Zheng H; Jiang L; Dai JG
Int J Clin Oncol; 2022 May; 27(5):871-881. PubMed ID: 35171361
[TBL] [Abstract][Full Text] [Related]
37. Elements and evolutionary determinants of genomic divergence between paired primary and metastatic tumors.
Sun R; Nikolakopoulos AN
PLoS Comput Biol; 2021 Mar; 17(3):e1008838. PubMed ID: 33730105
[TBL] [Abstract][Full Text] [Related]
38. Multiregional Sequencing Reveals Genomic Alterations and Clonal Dynamics in Primary Malignant Melanoma of the Esophagus.
Li J; Yan S; Liu Z; Zhou Y; Pan Y; Yuan W; Liu M; Tan Q; Tian G; Dong B; Cai H; Wu N; Ke Y
Cancer Res; 2018 Jan; 78(2):338-347. PubMed ID: 28972077
[TBL] [Abstract][Full Text] [Related]
39. Microenvironmental Influences on Metastasis Suppressor Expression and Function during a Metastatic Cell's Journey.
Liu W; Vivian CJ; Brinker AE; Hampton KR; Lianidou E; Welch DR
Cancer Microenviron; 2014 Dec; 7(3):117-31. PubMed ID: 24938990
[TBL] [Abstract][Full Text] [Related]
40. Molecular profiling identifies synchronous endometrial and ovarian cancers as metastatic endometrial cancer with favorable clinical outcome.
Reijnen C; Küsters-Vandevelde HVN; Ligtenberg MJL; Bulten J; Oosterwegel M; Snijders MPLM; Sweegers S; de Hullu JA; Vos MC; van der Wurff AAM; van Altena AM; Eijkelenboom A; Pijnenborg JMA
Int J Cancer; 2020 Jul; 147(2):478-489. PubMed ID: 32022266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
